1. Home
  2. GHRS vs METC Comparison

GHRS vs METC Comparison

Compare GHRS & METC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • METC
  • Stock Information
  • Founded
  • GHRS 2018
  • METC 2015
  • Country
  • GHRS Ireland
  • METC United States
  • Employees
  • GHRS N/A
  • METC N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • METC Coal Mining
  • Sector
  • GHRS Health Care
  • METC Energy
  • Exchange
  • GHRS Nasdaq
  • METC Nasdaq
  • Market Cap
  • GHRS 737.5M
  • METC 614.3M
  • IPO Year
  • GHRS 2021
  • METC 2017
  • Fundamental
  • Price
  • GHRS $14.76
  • METC $11.94
  • Analyst Decision
  • GHRS Strong Buy
  • METC Strong Buy
  • Analyst Count
  • GHRS 8
  • METC 3
  • Target Price
  • GHRS $30.63
  • METC $13.67
  • AVG Volume (30 Days)
  • GHRS 204.8K
  • METC 1.6M
  • Earning Date
  • GHRS 05-08-2025
  • METC 08-06-2025
  • Dividend Yield
  • GHRS N/A
  • METC 4.61%
  • EPS Growth
  • GHRS N/A
  • METC N/A
  • EPS
  • GHRS N/A
  • METC N/A
  • Revenue
  • GHRS N/A
  • METC $628,275,000.00
  • Revenue This Year
  • GHRS N/A
  • METC N/A
  • Revenue Next Year
  • GHRS N/A
  • METC $25.50
  • P/E Ratio
  • GHRS N/A
  • METC N/A
  • Revenue Growth
  • GHRS N/A
  • METC N/A
  • 52 Week Low
  • GHRS $6.00
  • METC $5.90
  • 52 Week High
  • GHRS $20.50
  • METC $14.29
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 66.16
  • METC 56.52
  • Support Level
  • GHRS $11.82
  • METC $9.75
  • Resistance Level
  • GHRS $12.94
  • METC $14.29
  • Average True Range (ATR)
  • GHRS 0.99
  • METC 1.28
  • MACD
  • GHRS 0.19
  • METC 0.03
  • Stochastic Oscillator
  • GHRS 84.53
  • METC 48.24

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About METC Ramaco Resources Inc.

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.

Share on Social Networks: